Are you Dr. Qureshi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
111 E 210th Street
Bronx, NY 10467Phone+1 718-430-4288Fax+1 718-430-8551
Summary
- Dr. Irfan Qureshi, MD is a board certified neurologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with Burke Rehabilitation Hospital and is an Assistant Professor at Albert Einstein College of Medicine.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2003 - 2006
- Johns Hopkins UniversityInternship, Internal Medicine, 2002 - 2003
- Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
- NY State Medical License 2006 - 2025
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 9 citationsNervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome.Harnadar Anand, Victoria Ende, Gurinder Singh, Irfan A. Qureshi, Timothy Q. Duong
Frontiers in Neuroscience. 2021-08-27 - Frontiers in neuroepigeneticsIrfan A. Qureshi, Mark F. Mehler
Neurobiology of Disease. 2021-03-12 - 25 citationsPredicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.Ali Ezzati, Danielle J Harvey, Christian G. Habeck, Ashkan Golzar, Irfan A. Qureshi
Journal of Alzheimer's Disease. 2020-01-01
Press Mentions
- Biohaven's Phase 3 Trial, and Other News: The Good, Bad and Ugly of BiopharmaJuly 22nd, 2020
- Biohaven's Verdiperstat, an Oral Myeloperoxidase Inhibitor, Selected for Platform Trial Collaboration at Massachusetts General Hospital's Healey & AMG Center for Amyotrophic Lateral Sclerosis (ALS)January 22nd, 2020
- Biohaven Provides Update on Phase 2/3 Alzheimers Disease Clinical Trial: Over 400 Patients EnrolledAugust 12th, 2019
- Join now to see all